Despite Patent Attack, Schering Will Bring Yaz To U.S.

Law360, New York (March 28, 2006, 12:00 AM EST) -- German pharmaceutical company Schering AG will forge ahead with its U.S. launch of the oral contraceptive Yaz in spite of a patent infringement suit brought against the company this week by its U.K. competitor, Warner Chilcott PLC.

Warner Chilcott announced on Monday that it had filed the suit in U.S. District Court for the District of New Jersey.

The U.K.-based company is accusing the German drugmaker of infringing a patent on its recently-approved Loestrin 24 Fe contraceptive by selling the oral contraceptive Yaz.

The patent at...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.